Abstract
Rhinitis medicamentosa, the syndrome of rebound nasal congestion secondary to prolonged topical intranasal use of vasoconstrictors, is reviewed. In this condition, the nasal airway is very obstructed; atrophic rhinitis is the most serious complication. Management consists of withdrawing the offending nasal spray and alleviating the nasal obstruction by means of any of several treatment modalities.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Baldwin R. L. Rhinitis medicamentosa (an approach to treatment). J Med Assoc State Ala. 1975 Aug;47(2):33–35. [PubMed] [Google Scholar]
- Barger G., Dale H. H. Chemical structure and sympathomimetic action of amines. J Physiol. 1910 Oct 11;41(1-2):19–59. doi: 10.1113/jphysiol.1910.sp001392. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Blue J. A. Rhinitis medicamentosa. Ann Allergy. 1968 Aug;26(8):425–429. [PubMed] [Google Scholar]
- Cass E., Kadar D., Stein H. A. Hazards of phenylephrine topical medication in persons taking propranolol. Can Med Assoc J. 1979 May 19;120(10):1261–1262. [PMC free article] [PubMed] [Google Scholar]
- Oliver G., Schäfer E. A. The Physiological Effects of Extracts of the Suprarenal Capsules. J Physiol. 1895 Jul 18;18(3):230–276. doi: 10.1113/jphysiol.1895.sp000564. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Stride R. D. Nasal decongestant therapy. Br J Clin Pract. 1967 Nov 11;21(11):541–548. [PubMed] [Google Scholar]
- WALKER J. S. Rhinitis medicamentosa. J Allergy. 1952 Mar;23(2):183–186. doi: 10.1016/0021-8707(52)90093-2. [DOI] [PubMed] [Google Scholar]
- Wilensky J. T., Woodward H. J. Acute systemic hypertension after conjunctival instillation of phenylephrine hydrochloride. Am J Ophthalmol. 1973 Jul;76(1):156–157. doi: 10.1016/0002-9394(73)90023-8. [DOI] [PubMed] [Google Scholar]